Cardiology Today Current Issue

The following articles appeared in the print edition of Cardiology Today.

Table of Contents

• The JUPITER trial and statins in primary prevention: Unequivocal benefit, or still a debatable issue? Roger S. Blumenthal, MD; Michael J. Blaha, MD, MPH; Rajesh Tota-Maharaj, MD
• Why the COGENT trial results matter Peter Libby, MD
• ACE inhibitor-related coughing shown substantially higher than labeling indicates
• ADVANCE: Experimental LVAD comparable to approved bridge-to-transplant devices
• Barbershop-based BP monitoring improved hypertension control rate
• Biomaterial utilizes body’s innate ability to heal damaged CV tissue
• EMPHASIS-HF: Eplerenone reduced death, hospitalization by 37% in systolic HF
• FDA approves endovascular system for thoracic aortic aneurysm repair
• FDA requests withdraw of sibutramine from U.S. market
• Healthy lifestyle in young adulthood leads to low CVD risk profile later in life
• Physicians speak out on implications of dabigatran approval
• Poor sleep increased risk for heart disease in adolescents
• ROCKET AF: Rivaroxaban, warfarin comparable in AF
• SMART AV: No significant advantage in LVESV reported for SmartDelay device
• SNPs identified for elevating risk of hypertension in Japanese patients
• SNPs implicated in increased risk for first CHD event
• Two biomarkers predicted higher risk for HF
• Type 2 diabetes increased risk for sudden cardiac death in patients following MI
• Adults, younger patients with congenital heart disease had similar catheter ablation IART outcomes
• CARDIoGRAM study to expand knowledge on the role of genetic variation in CAD
• Clopidogrel unaffected by CYP2C19 loss-of-function alleles in patients with ACS, AF
• Complication risks reported in CRT replacement surgeries
• Diastolic dyssynchrony more frequent than systolic dyssynchrony in HF
• Distinct characteristics of myocytes reported in patients with type 1 long-QT syndrome
• Gait speed predicted elderly at risk for cardiac surgery-related mortality, morbidity
• Hepatitis C increased risks for cerebrovascular-related death
• CYP2C19 allele linked with increased risk for major adverse CV events in patients given clopidogrel for PCI
• Metabolic syndrome no more predictive of adult type 2 diabetes, atherosclerosis than BMI alone
• Multiple MPI testing common, associated with high cumulative doses of radiation in patients
• No association between KIF6 Trp719Arg polymorphism and CAD risk
• Noninvasive 3.0-T MRI depicted coronary artery endothelial function
• Prompt revascularization vs. medical therapy improved health in patients with type 2 diabetes, ischemic heart disease
• RAFT: CRT, ICD plus medical therapy beneficial in patients with mild-to-moderate HF
• Researchers report additional high-risk symptoms in fetuses with hypoplastic left heart syndrome
• Stress test performed in more than half of patients within 2 years of revascularization
• TRACS: Differing blood transfusion strategies yield similar complication, death rates in cardiac surgery patients
• Prescribing and monitoring pearls for atrial antiarrhythmic therapies Michael Serra, PharmD